Industry News
How Melanoma Cells Circumvent The Immune System
Oct 12, 2012
Melanoma is so dangerous because it tends to metastasize early on. New treatment approaches utilize, among other things, the ability of the immune defense to search out and destroy malignant cells. Yet this strategy is often only temporarily effective... Read More
When Should Breast Screening Occur? It Depends
Oct 12, 2012
How often should breast screening occur, and when should they start? It used to be annually after a woman reached forty years of age. However, because of the risk of false positives, needless biopsies, extra financial costs, and the psychological distress overtreatment causes, the answer now is "It depends"... Read More
Targeting Dual Roles Of PARP-1 May Slow Cancer Growth And Progression
Oct 12, 2012
A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests. The team, led by Karen E. Knudsen, Ph.D... Read More
Cell Stiffness Of Ovarian Cancer Cells May Predict Metastatic Potential
Oct 12, 2012
New Georgia Tech research shows that cell stiffness could be a valuable clue for doctors as they search for and treat cancerous cells before they're able to spread. The findings, which are published in the journal PLoS One, found that highly metastatic ovarian cancer cells are several times softer than less metastatic ovarian cancer cells. Assistant Professor Todd Sulchek and Ph.D... Read More
The Study Of Cancer Could Be Revolutionized By Animal Models Developed By Researchers At IDIBELL And ICO
Oct 12, 2012
Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) have served to validate the effectiveness of a new drug against ovarian cancer resistant to cisplatin... Read More
Researchers Develop Interference Therapies To Knock Down Gene That Drives Mantle Cell Lymphoma
Oct 12, 2012
Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed... Read More
Incurable Blood Cancer Treatment Could Be In Sight
Oct 12, 2012
One of the characteristics of Mantle Cell Lymphoma (MCL) is the aggressive over-production of a cell-proliferation protein due to an overactive gene... Read More
Vulnerable Patients Benefit From Patient Navigation, Timely Cancer Diagnosis
Oct 12, 2012
Researchers at Boston Medical Center (BMC) have shown that patient navigation services help decrease the time to diagnosis for female patients who have received an abnormal result from a breast or cervical cancer screening... Read More
How Melanoma Cells Circumvent The Immune System
Oct 12, 2012
Melanoma is so dangerous because it tends to metastasize early on. New treatment approaches utilize, among other things, the ability of the immune defense to search out and destroy malignant cells. Yet this strategy is often only temporarily effective... Read More
Targeting Dual Roles Of PARP-1 May Slow Cancer Growth And Progression
Oct 12, 2012
A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests. The team, led by Karen E. Knudsen, Ph.D... Read More
Previous Page Next Page